- Home
- CRGX vs ORC Comparison
CRGX vs ORC Comparison
Compare CRGX & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- ORC
- Stock Information
- Founded
- CRGX 2021
- ORC 2010
- Country
- CRGX United States
- ORC United States
- Employees
- CRGX N/A
- ORC N/A
- Industry
- CRGX
- ORC Real Estate Investment Trusts
- Sector
- CRGX
- ORC Real Estate
- Exchange
- CRGX Nasdaq
- ORC Nasdaq
- Market Cap
- CRGX 628.6M
- ORC 623.6M
- IPO Year
- CRGX 2023
- ORC 2013
- Fundamental
- Price
- CRGX $3.70
- ORC $8.28
- Analyst Decision
- CRGX Hold
- ORC Buy
- Analyst Count
- CRGX 7
- ORC 3
- Target Price
- CRGX $4.67
- ORC $9.50
- AVG Volume (30 Days)
- CRGX 1.9M
- ORC 3.0M
- Earning Date
- CRGX 03-20-2025
- ORC 01-30-2025
- Dividend Yield
- CRGX N/A
- ORC 17.43%
- EPS Growth
- CRGX N/A
- ORC N/A
- EPS
- CRGX N/A
- ORC 0.58
- Revenue
- CRGX N/A
- ORC $54,406,000.00
- Revenue This Year
- CRGX N/A
- ORC N/A
- Revenue Next Year
- CRGX N/A
- ORC N/A
- P/E Ratio
- CRGX N/A
- ORC $14.41
- Revenue Growth
- CRGX N/A
- ORC N/A
- 52 Week Low
- CRGX $3.00
- ORC $7.41
- 52 Week High
- CRGX $33.92
- ORC $9.08
- Technical
- Relative Strength Index (RSI)
- CRGX 20.88
- ORC 62.14
- Support Level
- CRGX $3.00
- ORC $7.88
- Resistance Level
- CRGX $3.88
- ORC $8.38
- Average True Range (ATR)
- CRGX 0.92
- ORC 0.18
- MACD
- CRGX -1.00
- ORC 0.04
- Stochastic Oscillator
- CRGX 5.99
- ORC 81.51
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.